Provided by Tiger Trade Technology Pte. Ltd.

SELLAS Life Sciences Group Inc.

5.00
-0.4850-8.85%
Post-market: 5.030.0350+0.70%17:39 EDT
Volume:8.44M
Turnover:43.35M
Market Cap:899.10M
PE:-20.28
High:5.58
Open:5.41
Low:4.93
Close:5.48
52wk High:6.14
52wk Low:0.9516
Shares:180.00M
Float Shares:179.00M
Volume Ratio:0.74
T/O Rate:4.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2463
EPS(LYR):-0.2463
ROE:-66.88%
ROA:-34.74%
PB:12.69
PE(LYR):-20.28

Loading ...

Sellas Life Sciences Group Inc - Topline Data From Phase 2 Trial Expected in Q4 2026

THOMSON REUTERS
·
Mar 12

SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009

GlobeNewswire
·
Mar 12

What's Going With SELLAS Life Sciences Stock On Wednesday?

Benzinga_recent_news
·
Mar 05

NASA Announces Unexpected Additional Crewed Test Flight for Moon Program

Deep News
·
Feb 28

Sims (ASX:SGM) Valuation In Focus After SLS Growth Offsets Half Year Loss And Supports Dividend

Simply Wall St.
·
Feb 19

NASA Resumes Moon Mission Rehearsal After Fuel Leak Fix, Potential March Launch

Deep News
·
Feb 18

Sims Ltd Earnings Call Highlights SLS-Led Upswing

TIPRANKS
·
Feb 18

Sellas Life Sciences Group stellt neue Therapien für AML mit Fokus auf Galinpepimut-S und SLS009 vor

Reuters
·
Feb 04

The machine economy: AI will benefit crypto, or break it | Opinion

cryptonews
·
Jan 30

Mixed options sentiment in Sellas Life Sciences with shares down 1.75%

TIPRANKS
·
Jan 23

Amentum announces successful rollout of SLS rocket, Orion spacecraft from VAB

TIPRANKS
·
Jan 20

Sellas Life Sciences enters agreement with IMPACT-AML

TIPRANKS
·
Jan 14

Sellas Life Sciences Partners with IMPACT-AML to Expand SLS009 Trials into Europe

Reuters
·
Jan 14

Sellas Life Sciences Group Inc - Sls009 U.S. Enrollment Planned for Q1 2026, Europe Enrollment Anticipated in Q2 2026

THOMSON REUTERS
·
Jan 14

Sellas Life Sciences Enters Agreement With Impact-Aml to Expand Sls009 Clinical Program Into Europe

THOMSON REUTERS
·
Jan 14

SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe

GlobeNewswire
·
Jan 14

Sellas Life Sciences Raises $26.5 Million from Warrant Exercises

Reuters
·
Jan 08

A Look At SELLAS Life Sciences Group (SLS) Valuation As REGAL Phase 3 Trial Nears Final Event Trigger

Simply Wall St.
·
Jan 06

Social Buzz: Wallstreetbets Stocks Advance Premarket Monday; SELLAS Life Sciences Group, Chevron to Open Higher

MT Newswires Live
·
Jan 05

SELLAS Life Sciences Stock Is Surging Higher: What's Going On?

Benzinga_recent_news
·
Dec 30, 2025